Disease Control and Prevention Vaccine Market - by Product Type (Live-Attenuated, Inactivated, Recombinant Sub Unit and Toxoid), by Type (Monovalent and Multivalent), By Route of Administration (Oral and Injectable), by Age Group (Pediatric Vaccine and Adult Vaccine), and By Indication (Infectious Disease, Cancer and Other Indications) - Global Forecast to 2025

  • Published On : Apr 2018 |
  • Pages : 210 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Disease Control and Prevention Vaccine Market – Insights

Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide. According to European Centre for Disease Prevention and Control (ECDC), pertussis and invasive pneumococcal disease account for over 50% of vaccine preventable disease and over 60% of deaths. The completion immunization schedule from infant to adulthood significantly reduces burden of vaccine preventable disease. According to World Health Organization (WHO), 2018 factsheet, immunization prevents 2 to 3 million deaths annually. Furthermore, around 1.5 million deaths can be prevented by improving vaccine coverage. Several vaccine manufacturers’ work in partnership with civil society organization such as World Health Organization (WHO), United Nations Children's Fund (UNICEF), and Global Alliance for Vaccines and Immunisation (GAVI) Alliance to improve their vaccination program for reducing number of patient suffering from diseases

The global disease control and prevention vaccine market was valued at US$ 41.12 billion in 2017 and is expected to witness a CAGR of 12.1 % over the forecast period (2017–2025).

Global Disease Control and Prevention Vaccine Market, By Product Type

disease control and prevention vaccines market

Source: Coherent Market Insights Analysis (2018)

High Prevalence of Infectious Disease is Expected to Drive Growth of the Disease Control and Prevention Vaccine Market

High prevalence and increasing incidence of infectious disease are the major factors driving growth of the disease control and prevention vaccine market. According to the study published in journal Lancet Infectious Disease, around 54,984,661 cases of 45 infectious diseases were reported with average yearly incidence 417·98 per 100?000 in china between January 2004 and December 2013. Furthermore, Hepatitis B and tuberculosis has high incidence rate of 81.57 and 80.33 per 100,000, respectively. Moreover, World Health Organization (WHO) estimated 212 million malaria cases globally in 2015 with highest incidence in African regions.

Furthermore, the vaccines manufactured by novel technologies such as recombinant technology or cell-based vaccine production is decreasing the gap between demand and supply, which is expected to drive growth of the disease control and prevention vaccine market. For instance, in 2013, Protein Science Corporation received FDA approval for Flubok Trivalent Vaccine, produced by recombinant technology in the U.S. Moreover, in 2016, Seqirus received US FDA approval for Flucelvax Quadrivalent, cell-culture derived influenza vaccine.

Increasing Governmental Initiatives for Immunization Programs is Driving Growth of the Disease Control and Prevention Vaccine Market

Governmental and non-governmental organization partners are working together to provide better immunization to population for complete disease eradication. For instance, the Global Polio Eradication Initiative was a public-private partnership between five governmental agencies - the World Health Organization (WHO), Rotary International, the US Centers for Disease Control and Prevention (CDC), the United Nations Children’s Fund (UNICEF) and the Bill & Melinda Gates Foundation, aiming at polio eradication worldwide. The program was funded US$ 15 billion in the period 1988 - 2017, provided by public and private donors and 2013 - 2019 requirement was projected to US$ 7 billion. Furthermore, organization such as Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH) have partnered with the U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) to support development of advanced influenza vaccines. Such governmental approaches are expected to augment the growth of global disease control and prevention vaccine market over the forecast period (2017-2025). However, high cost of vaccine development is expected to restrain growth of the disease control and prevention vaccine market.

According to Access to Medicine Foundation index, 2017, vaccine market is dominated by four major players, collectively referred as 'big four': GSK, Merck & Co., Inc., Pfizer, and Sanofi. Big four contribute to 80% of the global vaccine revenue. Players vary significantly by portfolio and pipeline size. Other major players operating in market include AstraZeneca PLC, Sinovac Biotech Ltd., Astellas Pharma Inc., Serum Institute of India Pvt. Ltd., and Daiichi Sankyo.

Vaccines are the biological preparation used for stimulating antibody production to activate immune system against diseases such as influenza, Hepatitis A, Hepatitis B, Human Papillomavirus, Polio, and Rabies. High prevalence of infectious disease and increasing governmental initiative for implementing nationalized vaccination programme are expected to drive growth of the vaccine market, whereas high developmental cost of vaccine is expected to hamper growth of the vaccine market. For instance, according to the Centers for Disease Control and Prevention (CDC), 2015, flu vaccinations prevented an around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.

Market Dynamics

The global disease control and prevention vaccine market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel vaccines such as recombinant and cell-based technologies, resulting in increasing production of the vaccines. For instance, in 2018, collaboration between Austrian biotech Themis Bioscience and Oslo-based Coalition for Epidemic Preparedness Innovations (CEIP). CEIP will fund US$ 37.5 million for vaccine development for five years. Moreover, governmental bodied supports the research and development program leading to the development of improved form of presently available vaccines. For instance, in 2015, a National Institute of Allergy and Infectious Disease scientists engineered a protein to maintain the specific shape of the viral spike, stimulating the immune system to produce powerful anti-HIV antibodies. However, manufacturing cost as well as large gap between demand and supply leading to hike in pricing is expected to hinder the growth of disease control and prevention vaccination market.

Key features of the study:

  • This report provides in-depth analysis of the disease control and prevention vaccine  market and its Type, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global disease control and prevention vaccine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
  • Key companies covered as a part of this study include GlaxoSmithKline plc (GSK), Merck & Co. Inc., Sanofi, AstraZeneca PLC, Pfizer, Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Astellas Pharma Inc., and Daiichi Sankyo
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
  • The global disease control and prevention vaccine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for disease control and prevention vaccine market, research and consulting firms, new entrants and financial analysts.

Detailed Segmentation:

  • Global Disease Control and Prevention Vaccine Market, By Product Type:
    • Live-attenuated Vaccines
    • Inactivated Vaccines
    • Recombinant Vaccines
    • Toxoid Vaccines
  • Global Disease Control and Prevention Vaccine Market, By Type:
    • Monovalent Vaccine
    • Multivalent Vaccine
  • Global Disease Control and Prevention Vaccine Market, By Route of Administration:
    • Oral
    • Injectable
  • Global Disease Control and Prevention Vaccine Market, By Age Group:
    • Pediatric
    • Adults
  • Global Disease Control and Prevention Vaccine Market, By Indication:
    • Infectious Disease
    • Cancer
    • Other Indication
  • Global Disease Control and Prevention Vaccine Market, By Region:
    • North America
      • U.S.
        • U.S. Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • U.S. Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • U.S. Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • U.S. Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • U.S. Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Canada
        • Canada Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Canada Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Canada Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Canada Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Canada Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
    • Europe
      • U.K.
        • U.K. Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • U.K. Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • U.K. Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • U.K. Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • U.K. Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Germany
        • Germany Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Germany Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Germany Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Germany Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Germany Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Italy
        • Italy Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Italy Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Italy Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Italy Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Italy Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • France
        • France Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • France Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • France Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • France Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • France Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Spain
        • Spain Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Spain Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Spain Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Spain Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Spain Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Russia
        • Russia Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Russia Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Russia Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Russia Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Russia Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Rest of Europe
        • Rest of Europe Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Rest of Europe Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Rest of Europe Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Rest of Europe Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Rest of Europe Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
    • Asia-Pacific
      • China
        • China Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • China Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • China Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • China Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • China Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • India
        • India Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • India Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • India Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • India Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • India Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Japan
        • Japan Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Japan Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Japan Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Japan Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Japan Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • ASEAN
        • ASEAN Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • ASEAN Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • ASEAN Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • ASEAN Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • ASEAN Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Australia
        • Australia Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Australia Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Australia Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Australia Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Australia Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • South Korea
        • South Korea Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • South Korea Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • South Korea Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • South Korea Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • South Korea Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Rest of Asia Pacific
        • Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
    • Latin America
      • Brazil
        • Brazil Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Brazil Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Brazil Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Brazil Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Brazil Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Mexico
        • Mexico Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Mexico Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Mexico Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Mexico Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Mexico Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Rest of Latin America
        • Rest of Latin America Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Rest of Latin America Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Rest of Latin America Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Rest of Latin America Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Rest of Latin America Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
    • Middle East
      • GCC
        • GCC Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • GCC Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • GCC Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • GCC Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • GCC Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Israel
        • Israel Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Israel Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Israel Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Israel Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Israel Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Rest of Middle East
        • Rest of Middle East Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Rest of Middle East Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Rest of Middle East Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Rest of Middle East Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Rest of Middle East Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
    • Africa
      • North Africa
        • North Africa Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • North Africa Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • North Africa Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • North Africa Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • North Africa Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • Central Africa
        • Central Africa Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • Central Africa Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • Central Africa Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • Central Africa Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • Central Africa Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
      • South Africa
        • South Africa Disease Control and Prevention Vaccine Market, By Product Type:
          • Live-attenuated Vaccines
          • Inactivated Vaccines
          • Recombinant Vaccines
          • Toxoid Vaccines
        • South Africa Disease Control and Prevention Vaccine Market, By Type:
          • Monovalent Vaccine
          • Multivalent Vaccine
        • South Africa Disease Control and Prevention Vaccine Market, By Route of Administration:
          • Oral
          • Injectable
        • South Africa Disease Control and Prevention Vaccine Market, By Age Group:
          • Pediatric
          • Adults
        • South Africa Disease Control and Prevention Vaccine Market, By Indication:
          • Infectious Disease
          • Cancer
          • Other Indication
  • Company Profiles
    • GlaxoSmithKline plc (GSK) *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Merck & Co. Inc.
    • Sanofi
    • AstraZeneca PLC
    • Pfizer, Inc.
    • Serum Institute of India Pvt. Ltd.
    • Sinovac Biotech Ltd.
    • Astellas Pharma Inc.
    • Daiichi Sankyo

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Type
      • Market Snippet, By Route of Administration
      • Market Snippet, By Age Group
      • Market Snippet, By Indication
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Governmental Initiative
    • Product Pipeline
    • Regulatory Landscape
    • PEST Analysis
    • PORTER’S Five Forces
  4. Global Disease Control and Prevention Vaccines Market, By Product Type, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Live-attenuated Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Inactivated Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Recombinant Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Toxoid Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  5. Global Disease Control and Prevention Vaccines Market, By Type, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Monovalent Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Multivalent Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  6. Global Disease Control and Prevention Vaccines Market, By Route of Administration, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  7. Global Disease Control and Prevention Vaccines Market, By Age Group, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Pediatric Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Adult Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  8. Global Disease Control and Prevention Vaccines Market, By Indication, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Other Indications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  9. Global Disease Control and Prevention Vaccines Market, By Regions, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, By Region, 2015–2025
      • Regional Trends
    • North America
      • U.S.
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Canada
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
    • Europe
      • U.K.
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Germany
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Italy
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • France
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Spain
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Russia
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Rest of Europe
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
    • Asia Pacific
      • China
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Japan
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • India
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • ASEAN
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Australia
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • South Korea
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Rest of Asia Pacific
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
    • Latin America
      • Brazil
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Mexico
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Rest of Latin America
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
    • Africa
      • Northern Africa
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Central Africa
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • South Africa
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
    • Middle East
      • GCC Countries
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Israel
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
      • Rest of Middle East
        • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
        • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
  10. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • GlaxoSmithKline plc (GSK)
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Merck & Co. Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Sanofi
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • AstraZeneca PLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Serum Institute of India Pvt. Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Sinovac Biotech Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Astellas Pharma Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Daiichi Sankyo
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  11. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 47 market data tables and 45 figures on "Disease Control and Prevention Vaccines Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.